Home / People / Eleni Moraïtou
Portrait of Eleni Moraïtou

Eleni Moraïtou


CMS Francis Lefebvre Avocats
2 rue Ancelle
92522 Neuilly-sur-Seine
Languages French, Greek, English, German

Eleni is a member of the Competition and European Law team since May 2011.

Her practice focuses on issues related to the public sector and to the intervention in the market of public operators as well as to sector-specific regulation (State aid, exclusive rights, abuse of dominant position, opening to competition of regulated markets).

Eleni has also developed an expertise on all aspects of European law (national measures transposing EU directives, compatibility of national texts with European standards, introduction of national provisions in compliance with EU law).

Her activity includes advice as well as litigation before French and European courts and authorities (French jurisdictions up to the French Supreme Administrative Court, Court of Justice of the European Union, European Court of Human Rights, French Competition Authority, European Commission) in a wide variety of sectors: transport, pharmaceutical industry, energy, electronic communications, infrastructures, tobacco industry, fishing.

more less

Relevant experience

  • Associate within the Competition and European Law team of CMS Lefebvre Avocats (since 2011)
  • Lecturer at Paris V Descartes University, Post-graduate degree (M2) of Law of Health Products’ Industries – Courses of Competition Law applied to the health sector (since 2014)
more less


  • Qualification of French Lawyer (2012)
  • Greek diploma to practise as a Lawyer (“dikigoros”) (2011)
  • Post-graduate degree (Master 2) in Public Law, University of Paris II Panthéon-Assas (2010)
  • Master Degree in Law, University of Athens (2008)
more less


  • Member of  the French Association of Competition monitoring (AFEC)
  • Hauts-de-Seine Bar (2012) and Athens Bar (2011)
more less


  • The European Commission requires France to put an end to tax exemptions for ports, co-author - LEXplicite (26/12/2017 )
  • The European Commission approves French support for construction of the Paris-Charles-de-Gaulle airport express rail line, co-author - LEXplicite (19/12/2017)
  • The Constitutional Council censures the mechanism aimed at regulating the wholesale prices charged by tobacco manufacturers to their suppliers, co-author - LEXplicite (28/12/2017)
  • ARAFER requires SNCF Mobilités to review its accounting separation rules, co-author - LEXplicite (27/03/2017)
  • Tax rulings and State aid: the “Apple” decision marks a new stage in the European Commission's fight against abusive tax optimisation practices, co-author - Option Finance n° 1387 (31/10/2016)
  • Tax competition and State aid: after Luxembourg and the Netherlands, the European Commission concludes that selective tax advantages granted by Belgium are illegal under EU State aid rule, co-author - Option Finance n° 1353 (15/02/2016)
  • Two instruments at the disposal of the lawyer: Priority preliminary ruling on constitutionality (QPC) and question to the ECJ for a preliminary ruling - About the decision of the Constitutional Council No 2013-314P QPC of 4 April 2013, co-author - Review of the European Union n° 581 (September 2014)
more less


Show only
20 April 2020
CMS Ex­pert Guide to ad­vert­ising of medi­cines and med­ic­al devices
Ad­vert­ising of phar­ma­ceut­ic­als and med­ic­al devices is a chal­len­ging area for the Life Sci­ences and Health­care in­dustry.The leg­al frame­work is con­stantly chan­ging. Due to very few laws on this area, there...
20 April 2020
CMS Ex­pert Guide to can­nabis law and le­gis­la­tion
In re­cent years can­nabis trade and re­lated activ­ity has de­veloped in­to a growth busi­ness area. In the life sci­ences and health­care fields there have been in­creases in the num­bers of pa­tients hav­ing ac­cess...
08 April 2020
CMS Ex­pert Guide to state aid in the EU dur­ing coronavir­us crisis
The Coronavir­us (COV­ID-19) pan­dem­ic is hav­ing a sig­ni­fic­ant eco­nom­ic im­pact around the world. In re­sponse to this, EU Mem­ber States have es­tab­lished (or are plan­ning fur­ther) sup­port meas­ures for busi­nesses...
Cov­id-19 – Ad­just­ment of the dead­lines and pro­ced­ures for ex­amin­ing mer­gers...
On 25 March, the French gov­ern­ment's Coun­cil of Min­is­ters ad­op­ted an or­din­ance re­lat­ing to the ex­ten­sion of dead­lines ex­pir­ing dur­ing the emer­gency health situ­ation, as well as the ad­just­ment of pro­ced­ures...
State aid in re­sponse to the Cov­id-19 crisis
On 19 March 2020 the European Com­mis­sion ad­op­ted a tem­por­ary frame­work gov­ern­ing State Aid to al­low Mem­ber States to take all ne­ces­sary meas­ures aimed at sup­port­ing com­pan­ies weakened by the COV­ID-19...
Med­ic­al use of can­nabis In prin­ciple, the pro­duc­tion, man­u­fac­ture, trans­port, im­port, ex­port, hold­ing, of­fer, trans­fer, ac­quis­i­tion or use of can­nabis (plant and res­in) and THC are pro­hib­ited.Non­ethe­less...